Indirect evidence implicates a virus in the etiology of Multiple Sclerosis (MS) and more direct evidence shows that viruses can cause other human demyelinating diseases. Coronavirus, mouse hepatitis virus (MHV), strain A59 infection of weanling mice is a good animal model system for the study of virus induced demyelination. After the initial acute encephalitis, virus becomes impossible to detect during the chronic stages of disease while viral nucleic acids may be detected in white matter by in situ hybridization. Furthermore, MHV-A59 causes a persistent, productive, but non-lytic infection in primary glial cells in culture. The long term goal of this project is to determine the molecular basis for MHV-A59 persistence in glial cells in culture and in the mouse central nervous system (CNS) and to determine the relationship between viral persistence and chronic demyelination. In this proposal we plan to study the molecular basis for MHV-A59 persistence both in vitro in glial cell cultures and in vivo in C57BL/6 mice. More specifically we will: 1) characterize viral RNA expression using Northern blot analysis and in situ hybridization during persistent infection in glial cell cultures and the murine CNS and compare expression with that during lytic infection in fibroblasts; 2) compare the expression of viral structural and non-structural proteins during infection in glial cells and fibroblasts using immunoprecipitation and Western immunoblots using antibodies directed against individual viral proteins; 3) compare variants isolated from persistently infected glial cells (PI variants) with viruses isolated from infected animals and with wild type MHV-A59 as far as cytopathology and viral gene expression in vitro and virus spread and tropism in vivo; 4) further characterize the PI variants that are both attenuated in animals and deficient in the ability to induce cell fusion, by cloning and expression of wild type and variant peplomer S proteins; 5) use polymerase chain reaction methodology to amplify portions of viral sequences present during chronic infection in the mouse to determine if there are specific changes in viral gene expression that are associated with persistence in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Project (R01)
Project #
2R01NS021954-06A1
Application #
3403704
Study Section
Experimental Virology Study Section (EVR)
Project Start
1985-07-01
Project End
1996-01-31
Budget Start
1992-02-06
Budget End
1993-01-31
Support Year
6
Fiscal Year
1992
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Navas-Martin, Sonia; Brom, Maarten; Chua, Ming-Ming et al. (2007) Replicase genes of murine coronavirus strains A59 and JHM are interchangeable: differences in pathogenesis map to the 3'one-third of the genome. J Virol 81:1022-6
Weiss, Susan R; Navas-Martin, Sonia (2005) Coronavirus pathogenesis and the emerging pathogen severe acute respiratory syndrome coronavirus. Microbiol Mol Biol Rev 69:635-64
Navas-Martin, Sonia; Hingley, Susan T; Weiss, Susan R (2005) Murine coronavirus evolution in vivo: functional compensation of a detrimental amino acid substitution in the receptor binding domain of the spike glycoprotein. J Virol 79:7629-40
Navas-Martin, Sonia R; Weiss, Susan (2004) Coronavirus replication and pathogenesis: Implications for the recent outbreak of severe acute respiratory syndrome (SARS), and the challenge for vaccine development. J Neurovirol 10:75-85
Navas, Sonia; Weiss, Susan R (2003) Murine coronavirus-induced hepatitis: JHM genetic background eliminates A59 spike-determined hepatotropism. J Virol 77:4972-8
Tsai, Jean C; de Groot, Linda; Pinon, Josefina D et al. (2003) Amino acid substitutions within the heptad repeat domain 1 of murine coronavirus spike protein restrict viral antigen spread in the central nervous system. Virology 312:369-80
Zelus, Bruce D; Schickli, Jeanne H; Blau, Dianna M et al. (2003) Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37 degrees C either by soluble murine CEACAM1 receptors or by pH 8. J Virol 77:830-40
Tsai, Jean C; Zelus, Bruce D; Holmes, Kathryn V et al. (2003) The N-terminal domain of the murine coronavirus spike glycoprotein determines the CEACAM1 receptor specificity of the virus strain. J Virol 77:841-50
Navas-Martin, Sonia; Weiss, Susan R (2003) SARS: lessons learned from other coronaviruses. Viral Immunol 16:461-74
Das Sarma, Jayasri; Scheen, Esther; Seo, Su-Hun et al. (2002) Enhanced green fluorescent protein expression may be used to monitor murine coronavirus spread in vitro and in the mouse central nervous system. J Neurovirol 8:381-91

Showing the most recent 10 out of 55 publications